APG-157

N/A

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameAPG-157
Drug Alias NameAPG-157
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Mouth AbnormalitiesMouth Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAveta Biomics
China Registration ClassN/A

Develop Information

Active CompaniesAveta Biomics
Inactive CompaniesN/A
Active IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Mouth AbnormalitiesMouth Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A